Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 2 of 2
Tablet
Metformin 500mg Tab. (Uncoated) is a tablet formulated with Metformin 500mg . ( ). The listed active ingredient profile is Metformin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin
Tablet
Metformin HCI (SR) 500mg is a tablet formulated with Metformin HCI (SR) 500mg. The listed active ingredient profile is Metformin HCI, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin
Tablet
Metformin Hydrochloride(as Prolonged Release Form ) 1000mg + Glimepiride 0.5mg is a tablet formulated with Metformin Hydrochloride(as Form ) 1000mg + Glimepiride 0.5mg. The listed active ingredient profile is Metformin Hydrochloride; Glimepiride, placing
Tablet
Siaglipin 50 mg + Dapagliflozin propanedlol monohydrate Eq to dapaglilozine 10mg (Film coated tab) is a tablet formulated with Siaglipin 50 mg + Dapagliflozin propanedlol monohydrate Eq to dapaglilozine 10mg ( ). The listed active ingredient profile is Si
Tablet
Sitagliptin 100 mg + Dapaglilozin propanediol monohydrate Eq to dapagliflozine 10mg (Film coated tab) is a tablet formulated with Sitagliptin 100 mg + Dapaglilozin propanediol monohydrate Eq to dapagliflozine 10mg ( ). The listed active ingredient profile
Tablet
Sitagliptin Phosphate Monohydrate Eq. To Sitagliptin 50mg + Metformin Hydrochloride 500mg is a tablet formulated with Sitagliptin Phosphate Monohydrate Eq. To Sitagliptin 50mg + Metformin Hydrochloride 500mg. The listed active ingredient profile is Sitagl
Tablet
Sitagliptin Phosphate Monohydrate Eqg. To Sitagliptin 5Omg + Metformin Hydrochloride 1000mg is a tablet formulated with Sitagliptin Phosphate Monohydrate Eqg. To Sitagliptin 5Omg + Metformin Hydrochloride 1000mg. The listed active ingredient profile is Si
Tablet
Sitagliptin Phosphate Tablets 25 mg is a tablet formulated with Sitagliptin Phosphate 25 mg. The listed active ingredient profile is Sitagliptin Phosphate, placing the product in the oral antidiabetic category. The formulation contains one or more oral gl
Bilayered Tablet
Teneligliptin 20mg + Metformin Hydrochloride (Extended Release) 1000mg Tablets (Uncoated bilayered) is a bilayered tablet formulated with Teneligliptin 20mg + Metformin Hydrochloride ( ) 1000mg ( ). The listed active ingredient profile is Teneligliptin; M
Tablet
Teneligliptin Hydrobromlde Hydrate 20MG Tablets (film coated) is a tablet formulated with Teneligliptin Hydrobromlde Hydrate 20MG ( ). The listed active ingredient profile is Teneligliptin Hydrobromlde Hydrate, placing the product in the oral antidiabetic
Tablet
Teneligliptin Tablets IP 20mg (Film coated) is a tablet formulated with Teneligliptin IP 20mg ( ). The listed active ingredient profile is Teneligliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral gluc
Tablet
Tenellgliptin 20mg + Metformin Hydrochloride (Extended Release) 500mg Tablets (Uncoated blayered) is a tablet formulated with Tenellgliptin 20mg + Metformin Hydrochloride ( ) 500mg ( blayered). The listed active ingredient profile is Tenellgliptin; Metfor
Tablet
Vildagliptin 50 mg + Metformin HCI 1000 mg Tablets is a tablet formulated with Vildagliptin 50 mg + Metformin HCI 1000 mg. The listed active ingredient profile is Vildagliptin; Metformin HCI, placing the product in the oral antidiabetic category. The form
Tablet
Vildagliptin 50mg + Metformin Hydrochlortde 500mg Tablets (Film coated) is a tablet formulated with Vildagliptin 50mg + Metformin Hydrochlortde 500mg ( ). The listed active ingredient profile is Vildagliptin; Metformin Hydrochlortde, placing the product i
Tablet
Vildagliptin 50MG Tablet (Uncoated Tablet) is a tablet formulated with Vildagliptin 50MG ( ). The listed active ingredient profile is Vildagliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lo
Tablet
Voglibose 0.2mg + Metformin 500mg Tab. (Uncoated) is a tablet formulated with Voglibose 0.2mg + Metformin 500mg . ( ). The listed active ingredient profile is Voglibose; Metformin, placing the product in the oral antidiabetic category. The formulation con
Tablet
Voglibose 0.2mg Tab. (Uncoated) is a tablet formulated with Voglibose 0.2mg . ( ). The listed active ingredient profile is Voglibose, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin
Bilayered Tablet
Voglibose 0.2mg, Glimepiride Img + Metformin Hydrochloride 500mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Voglibose 0.2mg, Glimepiride Img + Metformin Hydrochloride 500mg ( ). The listed active ingredient profile is Voglibose; Gl
Bilayered Tablet
Voglibose 0.2mg. Glimepiide 2mg + Metformin Hydrochloide 500mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Voglibose 0.2mg. Glimepiide 2mg + Metformin Hydrochloide 500mg ( ). The listed active ingredient profile is Voglibose . Glime
Tablet
Voglibose lP 0.3 mg + Glimepride IP1 mg + Metformin Hcl IP SR 500 mg (Uncoated Tab) is a tablet formulated with Voglibose lP 0.3 mg + Glimepride IP1 mg + Metformin Hcl IP SR 500 mg ( ). The listed active ingredient profile is Voglibose lP; Glimepride IP1
Tablet
Voglibose O.3mg + Metformin 500mg Tab. (Uncoated) is a tablet formulated with Voglibose O.3mg + Metformin 500mg . ( ). The listed active ingredient profile is Voglibose O; Metformin, placing the product in the oral antidiabetic category. The formulation c
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
